Michael W. Panas, Ph.D.
Affiliations: | 2011 | Harvard University, Cambridge, MA, United States |
Area:
Immunology, Microbiology Biology, Molecular BiologyGoogle:
"Michael Panas"Parents
Sign in to add mentor| Norman Letvin | grad student | 2011 | Harvard | |
| (The identification and elimination of immunosuppressive Mycobacterium bovis BCG genes to create novel rBCG vectors that generate increased CD8+ T cell responses.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Panas MW, Sixsmith JD, White K, et al. (2014) Gene deletions in Mycobacterium bovis BCG stimulate increased CD8+ T cell responses. Infection and Immunity. 82: 5317-26 |
| Venkataswamy MM, Ng TW, Kharkwal SS, et al. (2014) Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells. Plos One. 9: e108383 |
| Panas MW, Jain P, Yang H, et al. (2014) Noncanonical SMC protein in Mycobacterium smegmatis restricts maintenance of Mycobacterium fortuitum plasmids. Proceedings of the National Academy of Sciences of the United States of America. 111: 13264-71 |
| Sixsmith JD, Panas MW, Lee S, et al. (2014) Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques. Clinical and Vaccine Immunology : Cvi. 21: 1385-95 |
| Panas MW, Letvin NL. (2014) Role for Gr-1+ cells in the control of high-dose Mycobacterium bovis recombinant BCG. Clinical and Vaccine Immunology : Cvi. 21: 1120-7 |
| Panas MW, Xie Z, Panas HN, et al. (2012) Trace amine associated receptor 1 signaling in activated lymphocytes. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 866-76 |
| Gillard GO, Bivas-Benita M, Hovav AH, et al. (2011) Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes. Plos Pathogens. 7: e1002141 |
| Gillard GO, Bivas-Benita M, Hovav A, et al. (2011) Correction: Thy1+Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes Plos Pathogens. 7 |
| Barker BR, Gladstone MN, Gillard GO, et al. (2010) Critical role for IL-21 in both primary and memory anti-viral CD8+ T-cell responses. European Journal of Immunology. 40: 3085-96 |
| Hovav AH, Santosuosso M, Bivas-Benita M, et al. (2009) X4 human immunodeficiency virus type 1 gp120 down-modulates expression and immunogenicity of codelivered antigens. Journal of Virology. 83: 10941-50 |